NCT02561741View on ClinicalTrials.gov

Pharmacokinetic, Bioavailability, and Safety Study of COV155 Administered in Healthy Subjects Under Fed and Fasted Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Pharmacokinetics
Interventions
DRUG

COV155

COV155 tablets

Sponsors

Lead Sponsor

Mallinckrodt
All Listed Sponsors
lead

Mallinckrodt

INDUSTRY